The Brain+ Team

EXECUTIVE TEAM

KIM BADEN-KRISTENSEN

Co-founder & CEO

Former Vice President of Marketing & Strategy @ world’s largest wind energy co. 5 years @ Boston Consulting Group. M.Sc. Management of Technology, CBS Cognitive Psychology studies, UCPH. Healthcare Innovation degree HARVARD Business School (Pasteur Program).

SIMON NIELSEN

Chief Science & Innovation Officer

12 years of experience as a biomedical engineer.
Experience from several medtech startups
Senior scientist & team mgr. at Coloplast.
Postdoc, Cognitive Neuroscience, University of Copenhagen.
PhD. Cognition and psychophysics, DTU.

BrainPlus_Feb_2023_Selection_LowResolution-209

HANNE LETH HILLMAN

Interim Chief Financial Officer

Experienced life science executive focused on finance, communications and investor relations (IR)
M.Sc. (Cand.Merc.Int), Business Administration and International Finance supplemented with a diploma in International Money and Finance – The Aarhus University School of Business and Social Sciences. Board leadership education from CBS Executive.

BERTIL STENGAARD JESSEN

Chief Financial Officer (Absent from May 2023 for family reasons)

Former head of a global strategic investment program at GN Store Nord. Corporate strategy and M&A advisory at Maersk and J.P. Morgan’s investment banking division.
MSc in Economics and Business Administration – Applied Economics and Finance from Copenhagen Business School.

PAULA PETCU

Chief Technology Officer

10+ years in Software Development, 7 years in Pharma. Formerly Head of Digital Technologies at Lundbeck. Tech nerd and team manager. One of Berlingske’s Top 100 Talent in Denmark. MSc in Computer Science from University of Copenhagen. Co-founded health tech companies FindZebra and Healthy Mind Tech.

BRIAN ØSTERGAARD

Business Development Manager

Business Development Manager
Entrepreneur in public health care and digital health with successful exit of his company in Autism & dementia care software.
25 years experience in selling into public and private health care sectors.

THE BOARD

ANDERS HÄRFSTRAND

Joined as chairman since Sep 2022

Chairman at Diurnal Group (DNI) and Non-Executive Director at Prothena Corporation (PRTA)

35 years of experience and a sustained successful global track record within global business development and new product commercialization in biotech and pharma.

JOHAN LUTHMAN

Board member since Sep 2022

EVP & Head of R&D at Lundbeck
30 years’ experience of pharmaceutical industry research and development in companies such as Lundbeck, Eisai US and Merck.

BETÜL SUSAMIS UNARAN

Board member since Sep 2022

Member of the Board of Directors of Ypsomed and Chief Strategy and Digital Officer at Zur Rose Group
20 years’ experience as a highly accomplished leader of building successful businesses and strong teams.